Colorectal cancer, malignant (ICD10 C18-C21): combined sexes
See also separate figures for colon (C18) and rectum / anus (C19-C21)
Five-year relative survival by diagnosis year and age at diagnosis
|
Five-year relative survival (with 95% confidence interval) by diagnosis year |
EUROCARE-4 |
EUROCARE-4 |
||||||||||
|
Age at diagnosis |
1994-97 |
1998-2002 |
2003-2007 |
2007-2009 |
##2000-2002 |
##2000-2002 |
||||||
|
cohort |
cohort |
cohort |
*hybrid |
Ireland |
Europe average |
|||||||
|
all 15-99 |
49.0% |
52.5% |
57.6% |
58.2% |
||||||||
|
(unstandardized) |
(47.5-50.5%) |
(51.2-53.8%) |
(56.0-59.1%) |
(56.5-59.8%) |
||||||||
|
all 15-99 |
48.9% |
52.4% |
57.0% |
57.2% |
54.3% |
56.2% |
||||||
|
(age-standardized)# |
(45.6-52.1%) |
(49.6-55.1%) |
(53.7-60.2%) |
(53.7-60.5%) |
(52.6-56.0%) |
(55.3-57.2%) |
||||||
|
15-44 |
50.2% |
56.1% |
64.0% |
63.1% |
||||||||
|
(43.5-56.4%) |
(50.4-61.3%) |
(57.6-69.6%) |
(56-69.4%) |
|||||||||
|
45-54 |
50.0% |
59.1% |
63.1% |
63.8% |
||||||||
|
(45.8-53.9%) |
(55.6-62.3%) |
(58.9-66.8%) |
(59.3-68%) |
|||||||||
|
55-64 |
50.6% |
57.7% |
60.5% |
62.5% |
||||||||
|
(47.7-53.4%) |
(55.1-60.1%) |
(57.4-63.5%) |
(59.3-65.4%) |
|||||||||
|
65-74 |
48.9% |
51.4% |
57.1% |
56.5% |
||||||||
|
(46.3-51.3%) |
(49.2-53.5%) |
(54.4-59.7%) |
(53.6-59.2%) |
|||||||||
|
75-99 |
46.9% |
45.5% |
49.8% |
49.5% |
||||||||
|
(43.7-50.1%) |
(42.8-48.2%) |
(46.7-53.0%) |
(46.2-52.8%) |
|||||||||
|
Footnotes: |
|
|
*Hybrid estimate for 2007-2009 is the most up-to-date survival estimate and is based on follow-up of all cases alive at any point during this period, |
|
|
supplemented by follow-up 2005-2009 for cases diagnosed in 2005-2006 (to provide more reliable estimation of the first two years of survival). |
|
|
In practice, the hybrid estimate for 2007-2009 is similar to the most recent (incomplete) cohort, i.e. cases diagnosed 2003-2007, reflecting substantial overlap of data. |
|
|
# Age-standardized figures use the standard patient population proposed for this cancer by: |
|
|
Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. |
|
|
(Population weights = age 15-44 x7000, 45-54 x12000, 55-64 x23000, 65-74 x29000, 75-99 x29000) |
|
|
## For comparison, the age-standardized average survival (2000-2002) is quoted for countries (including Ireland) that participated in the EUROCARE-4 study: |
|
|
Verdecchia A., Francisci S., Brenner H., et al. 2007. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796. |
|
|
Exclusions (as in EUROCARE): |
|
|
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient |
|
|
(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour. |
|
|
© National Cancer Registry Ireland 2011 (October 2011) Relative survival statistics for Irish cancer patients |
|